See more : Chifeng Jilong Gold Mining Co.,Ltd. (600988.SS) Income Statement Analysis – Financial Results
Complete financial analysis of Vicarious Surgical Inc. (RBOT) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Vicarious Surgical Inc., a leading company in the Medical – Devices industry within the Healthcare sector.
You may be interested
- Conexio Corporation (9422.T) Income Statement Analysis – Financial Results
- Mastercard Incorporated (MA.BA) Income Statement Analysis – Financial Results
- Treasury Metals Inc. (TSRMF) Income Statement Analysis – Financial Results
- HealthWarehouse.com, Inc. (HEWA) Income Statement Analysis – Financial Results
- E-Star Commercial Management Company Limited (6668.HK) Income Statement Analysis – Financial Results
Vicarious Surgical Inc. (RBOT)
About Vicarious Surgical Inc.
Vicarious Surgical Inc. engages in developing and selling single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. It offers Vicarious System, a single-incision surgical robot for ventral hernia repair. The company was incorporated in 2014 and is headquartered in Waltham, Massachusetts.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 1.85M | 1.94M | 316.00K | 0.00 | 0.00 |
| Gross Profit | -1.85M | -1.94M | -316.00K | 0.00 | 0.00 |
| Gross Profit Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 47.58M | 43.90M | 22.10M | 9.80M | 7.48M |
| General & Administrative | 26.86M | 29.72M | 13.50M | 2.33M | 2.05M |
| Selling & Marketing | 6.23M | 6.46M | 2.98M | 861.00K | 250.00K |
| SG&A | 33.09M | 36.18M | 16.47M | 3.19M | 2.30M |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 80.67M | 80.08M | 38.57M | 12.99M | 9.78M |
| Cost & Expenses | 80.67M | 80.08M | 38.57M | 12.99M | 9.78M |
| Interest Income | 4.43M | 1.44M | 20.00K | 113.00K | 469.00 |
| Interest Expense | 25.00K | 200.00K | 89.00K | 3.00K | 0.00 |
| Depreciation & Amortization | 1.85M | 1.94M | 316.00K | 157.00K | 104.00K |
| EBITDA | -69.19M | 7.30M | -34.80M | -161.18K | -9.68M |
| EBITDA Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | -80.67M | -80.08M | -38.57M | -12.99M | -9.78M |
| Operating Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | 9.60M | 85.24M | 3.02M | 110.00K | 469.00K |
| Income Before Tax | -71.07M | 5.16M | -7.27M | -12.88M | -9.31M |
| Income Before Tax Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 0.00 | -84.00M | -227.00K | 3.00K | -67.86K |
| Net Income | -71.07M | 89.16M | -7.04M | -12.88M | -9.31M |
| Net Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | -14.70 | 20.77 | -2.19 | -4.91 | -1.70 |
| EPS Diluted | -14.60 | 20.99 | -2.19 | -4.91 | -1.70 |
| Weighted Avg Shares Out | 4.83M | 4.29M | 3.22M | 2.62M | 5.47M |
| Weighted Avg Shares Out (Dil) | 4.87M | 4.25M | 3.22M | 2.62M | 5.47M |
Vicarious Surgical Reports First Quarter 2022 Financial Results
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes as well as both the cost and efficiency of surgical procedures, today announced financial results for...
Vicarious Surgical to Report First Quarter 2022 Financial Results on May 9, 2022
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics company seeking to improve the cost, efficiency, and outcomes of surgical procedures, today announced it will report financial results for the first quarter...
Vicarious Surgical to Report First Quarter 2022 Financial Results on May 9, 2022
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics company seeking to improve the cost, efficiency, and outcomes of surgical procedures, today announced it will report financial results for the first quarter...
Vicarious Surgical Announces Cleanroom Qualification for Manufacturing of the Vicarious System
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical, Inc. (“Vicarious Surgical” or the “Company”), a next-generation robotics company seeking to improve the cost, efficiency, and outcomes of surgical procedures, today announced qualification of its cleanroom for manufacturing of the Vicarious System. The cleanroom substantially...
Vicarious Surgical Announces Cleanroom Qualification for Manufacturing of the Vicarious System
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical, Inc. (“Vicarious Surgical” or the “Company”), a next-generation robotics company seeking to improve the cost, efficiency, and outcomes of surgical procedures, today announced qualification of its cleanroom for manufacturing of the Vicarious System. The cleanroom substantially...
Vicarious Surgical Appoints John Mazzola as Vice President of Operations
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes as well as the cost and efficiency of surgical procedures, today announced the appointment of John...
Vicarious Surgical Appoints John Mazzola as Vice President of Operations
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes as well as the cost and efficiency of surgical procedures, today announced the appointment of John...
Analysts Move To Sidelines On Vicarious Surgical After Regulatory Update
Piper Sandler has downgraded Vicarious Surgical Inc (NASDAQ: RBOT) to Neutral from Overweight with a price target of $7, down from $16, below expected Q4 results. A majority of the earnings call focused on the Company's regulatory update.
Vicarious Surgical Inc. (RBOT) CEO Adam Sachs on Q4 2021 Results - Earnings Call Transcript
Vicarious Surgical Inc. (RBOT) CEO Adam Sachs on Q4 2021 Results - Earnings Call Transcript
Vicarious Surgical Reports Fourth Quarter and Full Year 2021 Financial Results
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes as well as both the cost and efficiency of surgical procedures, today announced its preliminary unaudited...
Source: https://incomestatements.info
Category: Stock Reports